BACKGROUND: Cannabis is the most widely used illegal drug worldwide. Long-term use of cannabis is known to cause chronic bronchitis and airflow obstruction, but the prevalence of macroscopic emphysema, the dose-response relationship and the dose equivalence of cannabis with tobacco has not been determined. METHODS: A convenience sample of adults from the Greater Wellington region was recruited into four smoking groups: cannabis only, tobacco only, combined cannabis and tobacco and non-smokers of either substance. Their respiratory status was assessed using high-resolution CT (HRCT) scanning, pulmonary function tests and a respiratory and smoking questionnaire. Associations between respiratory status and cannabis use were examined by analysis of covariance and logistic regression. RESULTS: 339 subjects were recruited into the four groups. A dose-response relationship was found between cannabis smoking and reduced forced expiratory volume in 1 s to forced vital capacity ratio and specific airways conductance, and increased total lung capacity. For measures of airflow obstruction, one cannabis joint had a similar effect to 2.5-5 tobacco cigarettes. Cannabis smoking was associated with decreased lung density on HRCT scans. Macroscopic emphysema was detected in 1/75 (1.3%), 15/92 (16.3%), 17/91 (18.9%) and 0/81 subjects in the cannabis only, combined cannabis and tobacco, tobacco alone and non-smoking groups, respectively. CONCLUSIONS: Smoking cannabis was associated with a dose-related impairment of large airways function resulting in airflow obstruction and hyperinflation. In contrast, cannabis smoking was seldom associated with macroscopic emphysema. The 1:2.5-5 dose equivalence between cannabis joints and tobacco cigarettes for adverse effects on lung function is of major public health significance.
BACKGROUND: Cannabis is the most widely used illegal drug worldwide. Long-term use of cannabis is known to cause chronic bronchitis and airflow obstruction, but the prevalence of macroscopic emphysema, the dose-response relationship and the dose equivalence of cannabis with tobacco has not been determined. METHODS: A convenience sample of adults from the Greater Wellington region was recruited into four smoking groups: cannabis only, tobacco only, combined cannabis and tobacco and non-smokers of either substance. Their respiratory status was assessed using high-resolution CT (HRCT) scanning, pulmonary function tests and a respiratory and smoking questionnaire. Associations between respiratory status and cannabis use were examined by analysis of covariance and logistic regression. RESULTS: 339 subjects were recruited into the four groups. A dose-response relationship was found between cannabis smoking and reduced forced expiratory volume in 1 s to forced vital capacity ratio and specific airways conductance, and increased total lung capacity. For measures of airflow obstruction, one cannabis joint had a similar effect to 2.5-5 tobacco cigarettes. Cannabis smoking was associated with decreased lung density on HRCT scans. Macroscopic emphysema was detected in 1/75 (1.3%), 15/92 (16.3%), 17/91 (18.9%) and 0/81 subjects in the cannabis only, combined cannabis and tobacco, tobacco alone and non-smoking groups, respectively. CONCLUSIONS: Smoking cannabis was associated with a dose-related impairment of large airways function resulting in airflow obstruction and hyperinflation. In contrast, cannabis smoking was seldom associated with macroscopic emphysema. The 1:2.5-5 dose equivalence between cannabis joints and tobacco cigarettes for adverse effects on lung function is of major public health significance.
Authors: M Simoni; L Carrozzi; S Baldacci; M Pedreschi; F Di Pede; A Angino; F Pistelli; G Viegi Journal: Eur J Epidemiol Date: 2001 Impact factor: 8.082
Authors: D Robin Taylor; David M Fergusson; Barry J Milne; L John Horwood; Terrie E Moffitt; Malcolm R Sears; Richie Poulton Journal: Addiction Date: 2002-08 Impact factor: 6.526
Authors: F Mitsunobu; T Mifune; K Ashida; Y Hosaki; H Tsugeno; M Okamoto; S Harada; S Takata; Y Tanizaki Journal: Thorax Date: 2001-11 Impact factor: 9.139
Authors: Suzanne Marsh; Sarah Aldington; Mathew V Williams; Michael R Nowitz; Andrew Kingzett-Taylor; Mark Weatherall; Philippa M Shirtcliffe; Amanda A McNaughton; Alison Pritchard; Richard Beasley Journal: Respir Med Date: 2007-02-20 Impact factor: 3.415
Authors: Madeline A Morris; Sean R Jacobson; Gregory L Kinney; Donald P Tashkin; Prescott G Woodruff; Eric A Hoffman; Richard E Kanner; Christopher B Cooper; M Brad Drummond; R Graham Barr; Elizabeth C Oelsner; Barry J Make; MeiLan K Han; Nadia N Hansel; Wanda K O'Neal; Russell P Bowler Journal: Chronic Obstr Pulm Dis Date: 2018-01-24
Authors: Karim S Ladha; Varuna Manoo; Ali-Faizan Virji; John G Hanlon; Alexander Mclaren-Blades; Akash Goel; Duminda N Wijeysundera; Lakshmi P Kotra; Carlos Ibarra; Marina Englesakis; Hance Clarke Journal: Cannabis Cannabinoid Res Date: 2019-12-06
Authors: Maggie Davidson; Sue Reed; Jacques Oosthuizen; Greg O'Donnell; Pragna Gaur; Martyn Cross; Gary Dennis Journal: Int J Occup Environ Health Date: 2018-10-03